Press
Release

Complex Drug Product Development & Manufacturing: Lubrizol LifeSciences at AAPS 2017

Lubrizol LifeSciences is leading the way in drug and drug-device combination product development and commercial manufacturing for complex pharmaceuticals.

Please join Lubrizol LifeSciences at the 2017 AAPS Annual Meeting and Exposition (Booth #1521). The combination of Lubrizol’s polymer expertise with Particle Sciences’ leadership in complex drug formulation and manufacturing capabilities enable us to provide full-service solutions. Request a meeting with us or come to our booth to view presentations about:

• NEW! cGMP commercial manufacturing for complex drug products – adjacent to our existing development facility, offering a purpose-built infrastructure for manufacturing complex products, including: sterile and aseptic products, nano- and micro-particulates, drug eluting devices, suspensions, emulsions, highly potent compounds and controlled substances
• Advanced drug delivery capabilities – full service contract development and manufacturing for nanoparticle microparticles, drug eluting devices, highly potent compounds and other non-traditional dosage forms with full analytical and bioanalytical support
• Transform™ Films – the only hydratable topical film that offers wide API compatibility, simplified loading techniques and increased drug delivery efficiency for transdermal applications

Not able to attend?
Check your inbox for our follow-up post-show email. It will contain useful links, as well as additional information. Can’t wait? Contact your LifeSciences representative by emailing LifeSciences@Lubrizol.com or visiting us online: Lubrizol.com/LifeSciences.